Geovax ceo selected as a recipient of the 2022 georgia titan 100

Atlanta, ga, feb. 22, 2022 (globe newswire) -- via  newmediawire -- geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer, announced today that its chairman & ceo, david dodd, has been selected as a 2022 georgia titan 100.
GOVX Ratings Summary
GOVX Quant Ranking